Used in pharmaceutical research as a key intermediate for developing compounds with potential antitumor and enzyme inhibitory activities, particularly as a kinase inhibitor involved in cell signaling pathways that regulate cancer cell proliferation and survival. This positions it as a promising lead for anticancer drug development.

Its structure, featuring a benzimidazole core and methoxybenzamide group, facilitates strong binding to biological targets via hydrogen bonding and π-π interactions, enhancing its utility in designing bioactive molecules. It also shows potential for central nervous system applications, especially in research on chronic neurodegenerative diseases like Alzheimer's or Parkinson's.

Preclinical studies have demonstrated anti-inflammatory effects and moderate antimicrobial activity, particularly against Gram-positive bacteria and fungi, suggesting opportunities for new anti-infective agents.

Overall, this compound serves as a valuable scaffold in medicinal chemistry for addressing cancer, inflammation, and infectious diseases.